Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Digital Storytelling and Breastfeeding Education

10. august 2026 oppdatert av: Zübeyde Ceylan

Evaluatıon of the Effect of Breastfeedıng Educatıon Delıvered Usıng Dıgıtal Storytellıng Methods on Mothers' Breastfeedıng Success and Breastfeedıng Self-effıcacy

The aim of this study was to evaluate the effect of breastfeeding education provided using the digital storytelling method on mothers' breastfeeding self-efficacy and breastfeeding success. The study was conducted using a quasi-experimental pretest-posttest control group design. A total of 216 postpartum women participated in the study, including 108 women in the intervention group and 108 women in the control group. The intervention group received breastfeeding education based on the digital storytelling method, while the control group received routine breastfeeding education provided in the hospital. Breastfeeding self-efficacy and breastfeeding success were evaluated after the intervention.

Studieoversikt

Detaljert beskrivelse

Breastfeeding is one of the most important factors affecting maternal and infant health. Educational interventions may improve breastfeeding outcomes by increasing mothers' confidence and knowledge regarding breastfeeding practices. Digital storytelling is an innovative educational approach that combines visual, audio, and narrative elements to improve learning experiences.

This study was conducted to evaluate the effectiveness of digital storytelling-based breastfeeding education on breastfeeding self-efficacy and breastfeeding success among postpartum women. The study was carried out between September 2024 and December 2025 in the postpartum unit of Etlik City Hospital. Participants were assigned to either an intervention group receiving digital storytelling-based breastfeeding education or a control group receiving standard breastfeeding education.

Data were collected using a Demographic Information Form, the Breastfeeding Self-Efficacy Scale-Short Form, and the Bristol Breastfeeding Assessment Tool. The findings of the study are expected to contribute to the development of innovative breastfeeding education strategies and support evidence-based maternal health practices.

Studietype

Observasjonsmessig

Registrering (Faktiske)

216

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Ankara
      • Ankara, Ankara, Tyrkia (Türkiye), 06010
        • Etlik City Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

The study population consisted of postpartum women hospitalized in the postpartum unit of Etlik City Hospital between September 2024 and December 2025. A total of 216 postpartum women participated in the study.

Beskrivelse

Inclusion Criteria:

  • Women aged 18 years and older
  • Postpartum women
  • Able to communicate in Turkish
  • Literate
  • Healthy mother and healthy newborn
  • Voluntarily agreed to participate in the study

Exclusion Criteria:

  • Refusal to participate in the study
  • Mothers with conditions preventing breastfeeding
  • Mothers with severe maternal or neonatal complications
  • Communication problems preventing participation

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Experimental Group
Participants received breastfeeding education prepared using the digital storytelling method. Breastfeeding self-efficacy and breastfeeding success were evaluated after the intervention.
Control Group
Participants received routine breastfeeding education provided by the hospital. Breastfeeding self-efficacy and breastfeeding success were evaluated after the intervention.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Breastfeeding Self-Efficacy
Tidsramme: Within 24 hours after breastfeeding education
The Breastfeeding Self-Efficacy Scale is a 33-item scale originally developed by Dennis in 1999. Subsequently, in 2003, she developed the Short Form of the Breastfeeding Self-Efficacy Scale by reducing it to 14 items. It is a 5-point Likert-type scale. Scores range from a minimum of 14 to a maximum of 70; higher scores indicate greater breastfeeding self-efficacy. Dennis states that the scale is suitable for use during the postpartum period. Aluş Tokat, Okumuş, and Dennis conducted a reliability and validity study of the Turkish version of the short-form scale; they determined it to be suitable for the Turkish culture, finding a Cronbach's alpha value of 0.86.
Within 24 hours after breastfeeding education

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Breastfeeding Success
Tidsramme: 5 and 12 hours after breastfeeding education
It is a scale developed by Ingram et al. in 1998 to assess the breastfeeding process. Its Turkish validity and reliability were established by Dolgun et al. in 2018, yielding a Cronbach's alpha value of 0.77. The scale evaluates breastfeeding across four main categories: positioning, latching, observable sucking ability, and maternal comfort. Each criterion is scored on a scale of 0 to 2, resulting in a total possible score of 8. Higher scores indicate greater breastfeeding success. The BBAT is designed for use in breastfeeding support and education programs, serving as a tool for healthcare professionals and mothers to assess the breastfeeding process.
5 and 12 hours after breastfeeding education

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. september 2024

Primær fullføring (Faktiske)

30. desember 2025

Studiet fullført (Faktiske)

30. desember 2025

Datoer for studieregistrering

Først innsendt

13. juni 2026

Først innsendt som oppfylte QC-kriteriene

13. juni 2026

Først lagt ut (Faktiske)

18. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

12. august 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

10. august 2026

Sist bekreftet

1. august 2026

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere